Patents by Inventor Marie-Eve Rochette

Marie-Eve Rochette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detection of toxigenic strains of
    Patent number: 9863007
    Abstract: Primers and probes for detection of toxin-producing (toxigenic) strains of Clostridium difficile, and to methods of detecting toxigenic strains using these primers and probes. Toxigenic strains of C. difficile are detected by nucleic acid-based amplification methods using particular primers and probes that bind to the toxin B (TcdB) gene. These primers and probes are used to amplify C. difficile nucleic acids in clinical samples to determine the presence of these toxigenic strains.
    Type: Grant
    Filed: June 26, 2015
    Date of Patent: January 9, 2018
    Assignee: Geneohm Sciences Canada, Inc.
    Inventors: Nancy Paquette, Marie-Eve Rochette, Rachel Labourdette
  • DETECTION OF TOXIGENIC STRAINS OF CLOSTRIDIUM DIFFICILE
    Publication number: 20150292004
    Abstract: Primers and probes for detection of toxin-producing (toxigenic) strains of Clostridium difficile, and to methods of detecting toxigenic strains using these primers and probes. Toxigenic strains of C. difficile are detected by nucleic acid-based amplification methods using particular primers and probes that bind to the toxin B (TcdB) gene. These primers and probes are used to amplify C. difficile nucleic acids in clinical samples to determine the presence of these toxigenic strains.
    Type: Application
    Filed: June 26, 2015
    Publication date: October 15, 2015
    Inventors: Nancy Paquette, Marie-Eve Rochette, Rachel Labourdette
  • Detection of toxigenic strains of
    Patent number: 9096638
    Abstract: Primers and probes for detection of toxin-producing (toxigenic) strains of Clostridium difficile, and to methods of detecting toxigenic strains using these primers and probes. Toxigenic strains of C. difficile are detected by nucleic acid-based amplification methods using particular primers and probes that bind to the toxin B (TcdB) gene. These primers and probes are used to amplify C. difficile nucleic acids in clinical samples to determine the presence of these toxigenic strains.
    Type: Grant
    Filed: September 3, 2008
    Date of Patent: August 4, 2015
    Assignee: GENEOHM SCIENCES CANADA, INC.
    Inventors: Nancy Paquette, Marie-Eve Rochette, Rachel Labourdette
  • DETECTION OF TOXIGENIC STRAINS OF CLOSTRIDIUM DIFFICILE
    Publication number: 20090208948
    Abstract: Primers and probes for detection of toxin-producing (toxigenic) strains of Clostridium difficile, and to methods of detecting toxigenic strains using these primers and probes. Toxigenic strains of C. difficile are detected by nucleic acid-based amplification methods using particular primers and probes that bind to the toxin B (TcdB) gene. These primers and probes are used to amplify C. difficile nucleic acids in clinical samples to determine the presence of these toxigenic strains.
    Type: Application
    Filed: September 3, 2008
    Publication date: August 20, 2009
    Applicant: Genohm Sciences Canada, Inc.
    Inventors: Nancy Paquette, Marie-Eve Rochette, Rachel Lobourdette